Clincosm LogoSign in Get a demo

hormone refractory prostate cancer

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hormone Refractory Prostate Cancer Trial in Seoul (TKI258)

Completed
  • Hormone Refractory Prostate Cancer
  • Seoul, Chongro-ku, Korea, Republic of
  • +1 more
Feb 16, 2021

Hormone Refractory Prostate Cancer Trial in United States (LBH589)

Terminated
  • Hormone Refractory Prostate Cancer
  • Boston, Massachusetts
  • +4 more
Dec 16, 2020

Hormone Refractory Prostate Cancer Trial in United States (Docetaxel, TroVax)

Terminated
  • Hormone Refractory Prostate Cancer
  • San Bernardino, California
  • +6 more
Oct 8, 2020

Hormone Refractory Prostate Cancer, Metastatic Prostate Carcinoma Trial in China (SHR3680)

Unknown status
  • Hormone Refractory Prostate Cancer
  • Metastatic Prostate Carcinoma
  • Beijing, Beijing, China
  • +11 more
May 12, 2020

Hormone Refractory Prostate Cancer Trial in United States (ABI-008)

Completed
  • Hormone Refractory Prostate Cancer
  • Ann Arbor, Michigan
  • +3 more
Nov 18, 2019

Hormone Refractory Prostate Cancer Trial in Iowa City (ADENOVIRUS/PSA VACCINE)

Unknown status
  • Hormone Refractory Prostate Cancer
  • ADENOVIRUS/PSA VACCINE
  • Iowa City, Iowa
    Holden Comprehensive Cancer Center
Oct 24, 2019

Prostate Cancer, Hormone Refractory Prostate Cancer Trial in United States (MDV3100)

Completed
Has Results
  • Prostate Cancer
  • Hormone Refractory Prostate Cancer
  • Boston, Massachusetts
  • +8 more
Sep 10, 2019

Prostate Cancer Metastatic, Hormone Refractory Prostate Cancer, Castration-resistant Prostate Cancer Trial in United States

Completed
Has Results
  • Prostate Cancer Metastatic
  • +2 more
  • sipuleucel-T
  • abiraterone acetate
  • La Jolla, California
  • +20 more
Mar 5, 2019

PD-1 Knockout Engineered T Cells for Castration Resistant

Withdrawn
  • Hormone Refractory Prostate Cancer
  • PD-1 Knockout T Cells
  • +2 more
  • Beijing, Beijing, China
    Department of Urology Peking University First Hospital
Mar 4, 2019

Hormone Refractory Prostate Cancer, Bone Metastases Trial (Radium-223 dichloride (BAY88-8223))

Completed
  • Hormone Refractory Prostate Cancer
  • Bone Metastases
  • Radium-223 dichloride (BAY88-8223)
  • (no location specified)
Dec 17, 2018

Hormone Refractory Prostate Cancer Trial (Denosumab, Placebo)

Completed
Has Results
  • Hormone Refractory Prostate Cancer
  • Denosumab
  • Placebo
  • (no location specified)
Sep 20, 2018

Hormone Refractory Prostate Cancer, Recurrent Prostate Cancer Trial in Canada, United States (cediranib maleate, dasatinib)

Completed
Has Results
  • Hormone Refractory Prostate Cancer
  • Recurrent Prostate Cancer
  • Peoria, Illinois
  • +7 more
Jul 9, 2018

Hormone Refractory Prostate Cancer Trial in Spain (Cabazitaxel 10 mg/m2)

Completed
  • Hormone Refractory Prostate Cancer
  • Cabazitaxel 10 mg/m2
  • Santiago de Compostela, A Coruña, Spain
  • +11 more
Jun 29, 2017

Castrate-Resistant Prostate Cancer, Hormone Refractory Prostate Cancer Trial in Worldwide (custirsen sodium, isotonic, 0.9%

Terminated
  • Castrate-Resistant Prostate Cancer
  • Hormone Refractory Prostate Cancer
  • custirsen sodium
  • +4 more
  • La Verne, California
  • +32 more
Oct 7, 2016

Hormone Refractory Prostate Cancer, Bone Metastases Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo,

Completed
Has Results
  • Hormone Refractory Prostate Cancer
  • Bone Metastases
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +2 more
  • Los Angeles, California
  • +134 more
Apr 27, 2016

Hormone Refractory Prostate Cancer Trial in Durham (RAD001)

Completed
Has Results
  • Hormone Refractory Prostate Cancer
  • Durham, North Carolina
    Duke University MEdical Center
Feb 12, 2015

Hormone Refractory Prostate Cancer Trial in Tianjin (Docetaxel & Prednisone, DP & Targeted drugs, cisplatin & Etoposide)

Unknown status
  • Hormone Refractory Prostate Cancer
  • Docetaxel & Prednisone
  • +3 more
  • Tianjin, Tianjin, China
    Department of Interventional Oncology, Tianjin Medical Universit
Aug 4, 2014

Prostate Cancer, Hormone Refractory Prostate Cancer Trial in Worldwide (Satraplatin, Prednisone)

Completed
  • Prostate Cancer
  • Hormone Refractory Prostate Cancer
  • Birmingham, Alabama
  • +210 more
Aug 1, 2012

Hormone Refractory Prostate Cancer Trial in Columbus (Sargramostim, Docetaxel, Prednisone)

Terminated
  • Hormone Refractory Prostate Cancer
  • Columbus, Ohio
    Veeda Oncology
May 9, 2012

Radiotherapy vs Observation for CRPC

Unknown status
  • Hormone Refractory Prostate Cancer
    • Zhengzhou, Henan, China
      the first affiliated hospital of Zhengzhou University
    May 3, 2012

    Hormone Refractory Prostate Cancer Trial in Gainesville (CV9103)

    Terminated
    Has Results
    • Hormone Refractory Prostate Cancer
    • CV9103
    • Gainesville, Florida
      University of Florida, College of Medicine
    Mar 29, 2012

    Hormone Refractory Prostate Cancer Trial in India (Mycobacterium w., Docetaxel)

    Terminated
    • Hormone Refractory Prostate Cancer
    • New Delhi, Delhi, India
    • +13 more
    Mar 9, 2012

    Hormone Refractory Prostate Cancer Trial in Duarte (Bafetinib)

    Completed
    • Hormone Refractory Prostate Cancer
    • Duarte, California
      City of Hope Medical Center
    Dec 14, 2011

    Hormone Refractory Prostate Cancer Trial in Russian Federation, United States (AT-101, prednisone and docetaxel, , prednisone

    Completed
    • Hormone Refractory Prostate Cancer
    • AT-101, prednisone and docetaxel
    • placebo, prednisone and docetaxel
    • Colorado Springs, Colorado
    • +34 more
    Nov 8, 2010

    Hormone Refractory Prostate Cancer Trial in Canada (Patupilone)

    Completed
    • Hormone Refractory Prostate Cancer
    • Calgary, Alberta, Canada
    • +4 more
    Nov 3, 2010